Bio-Rad Laboratories Inc Total Assets
Bio-Rad Laboratories Inc total assets. Based on the latest financial reports, Bio-Rad Laboratories Inc (BIO-B) holds total assets worth $9.79 Billion USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see BIO-B company net worth for the company's overall valuation and market capitalisation.
Total Assets of Bio-Rad Laboratories Inc (1985–2025)
Total assets of Bio-Rad Laboratories Inc from 1985 to 2025. This chart illustrates how Bio-Rad Laboratories Inc's total assets have evolved over time, based on quarterly financial data. See BIO-B live share price for real-time trading data and today's change.
Bio-Rad Laboratories Inc - Asset Composition Analysis
Bio-Rad Laboratories Inc Total Assets Breakdown (December 2025)
Bio-Rad Laboratories Inc total assets breakdown as of December 2025. Bio-Rad Laboratories Inc's total assets of $9.79 Billion consist of 27.5% current assets and 72.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 5.0% |
| Accounts Receivable | $472.50 Million | 4.5% |
| Inventory | $740.70 Million | 7.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $174.30 Million | 1.7% |
| Goodwill | $579.80 Million | 5.5% |
Asset Composition Trend (1985–2025)
This chart illustrates how Bio-Rad Laboratories Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore BIO-B working capital efficiency to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Bio-Rad Laboratories Inc's current assets represent 27.5% of total assets in 2025, a decrease from 75.4% in 1985.
- Cash Position: Cash and equivalents constituted 5.0% of total assets in 2025, down from 8.4% in 1985.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 0.0% in 1985.
- Asset Diversification: The largest asset category is inventory at 7.0% of total assets.
Bio-Rad Laboratories Inc Competitors by Total Assets
Key competitors of Bio-Rad Laboratories Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
GN Store Nord
CO:GN
|
Denmark | Dkr29.23 Billion |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212
|
China | CN¥1.86 Billion |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$123.37 Million |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
VIROMED MEDICAL NA O.N.
XETRA:VME
|
Germany | €13.91 Million |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Bio-Rad Laboratories Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.21 | 5.99 | 3.90 |
| Quick Ratio | 2.37 | 4.43 | 2.88 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $2.03 Billion | $2.53 Billion | $1.70 Billion |
Bio-Rad Laboratories Inc - Advanced Valuation Insights
This section examines the relationship between Bio-Rad Laboratories Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.16 |
| Latest Market Cap to Assets Ratio | 0.18 |
| Asset Growth Rate (YoY) | 12.9% |
| Total Assets | $10.58 Billion |
| Market Capitalization | $1.92 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Bio-Rad Laboratories Inc's assets below their book value (0.18x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Bio-Rad Laboratories Inc's assets grew by 12.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Bio-Rad Laboratories Inc (1985–2025)
The table below shows the annual total assets of Bio-Rad Laboratories Inc from 1985 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $10.58 Billion | +12.95% |
| 2024-12-31 | $9.36 Billion | -23.86% |
| 2023-12-31 | $12.30 Billion | -8.91% |
| 2022-12-31 | $13.50 Billion | -24.15% |
| 2021-12-31 | $17.80 Billion | +37.21% |
| 2020-12-31 | $12.97 Billion | +61.98% |
| 2019-12-31 | $8.01 Billion | +42.73% |
| 2018-12-31 | $5.61 Billion | +31.31% |
| 2017-12-31 | $4.27 Billion | +10.97% |
| 2016-12-31 | $3.85 Billion | +3.80% |
| 2015-12-31 | $3.71 Billion | +11.03% |
| 2014-12-31 | $3.34 Billion | -1.40% |
| 2013-12-31 | $3.39 Billion | -1.59% |
| 2012-12-31 | $3.44 Billion | +11.20% |
| 2011-12-31 | $3.10 Billion | +1.11% |
| 2010-12-31 | $3.06 Billion | +20.78% |
| 2009-12-31 | $2.54 Billion | +24.47% |
| 2008-12-31 | $2.04 Billion | +3.33% |
| 2007-12-31 | $1.97 Billion | +23.52% |
| 2006-12-31 | $1.60 Billion | +11.89% |
| 2005-12-31 | $1.43 Billion | +4.01% |
| 2004-12-31 | $1.37 Billion | +38.18% |
| 2003-12-31 | $992.60 Million | +37.73% |
| 2002-12-31 | $720.70 Million | +5.36% |
| 2001-12-31 | $684.03 Million | +5.84% |
| 2000-12-31 | $646.28 Million | -3.38% |
| 1999-12-31 | $668.90 Million | +82.11% |
| 1998-12-31 | $367.30 Million | +4.38% |
| 1997-12-31 | $351.90 Million | +23.52% |
| 1996-12-31 | $284.90 Million | -0.07% |
| 1995-12-31 | $285.10 Million | +8.12% |
| 1994-12-31 | $263.70 Million | +1.46% |
| 1993-12-31 | $259.90 Million | -4.69% |
| 1992-12-31 | $272.70 Million | +7.74% |
| 1991-12-31 | $253.10 Million | +18.71% |
| 1990-12-31 | $213.20 Million | +15.62% |
| 1989-12-31 | $184.40 Million | +18.74% |
| 1988-12-31 | $155.30 Million | +17.65% |
| 1987-12-31 | $132.00 Million | +29.92% |
| 1986-12-31 | $101.60 Million | +42.10% |
| 1985-12-31 | $71.50 Million | -- |
About Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, pu… Read more